Embryo-derived trypsin-induced calcium entry is inhibited by endometrial infertility factor, LEFTY2

Zhiqi Yang ¹ Jing Yan ^2,3 Steffen Kull ¹ Md. Alauddin ¹ Sara Yvonne Brucker ¹ Melanie Henes ¹ Florian Lang ² Madhuri S Salker ^1*

• ¹ Research Institute for Women's Health, University Hospital and Faculty of Medicine, University of Tübingen, Tübingen, Germany
• ² Institute of Physiology, University Hospital and Faculty of Medicine, University of Tübingen, Tübingen, Baden-Württemberg, Germany
• ³ Department of Physiology, Jining Medical University, Jining, China

A transient window of uterine receptivity ensures that embryos implant in an optimal endometrial environment. Failure to establish or premature closure of the implantation window is thought to be a major cause of infertility, which affects many couples globally. Embryos release trypsin, which designates its developmental potential and plays a crucial role in implantation. Calcium (Ca 2+ ) signalling participates in receptivity and is thus a prerequisite for embryo implantation. Left-right determination factor 2 (LEFTY2) is a negative regulator of endometrial receptivity and is associated with unexplained infertility. We hypothesize that LEFTY2 impedes Ca 2+ entry induced by trypsin in endometrial cells. In silico analysis was performed to investigate classical trypsin pathway genes in human embryos. Trypsin levels from single human embryo conditioned medium were subject to ELISA. To determine if trypsin signals can modulate calcium entry, intracellular calcium [Ca 2+ ]i was determined utilizing Fura-2 fluorescence in human endometrial epithelial cells (Ishikawa cells). Bioinformatic analysis on publicly available single cell sequencing data was used to investigate the expression of L-Type Calcium channel (CACNA1C) in endometrium. qRT-PCR and immunofluorescence were used to quantify L-Type Calcium channel abundance. We report that the trypsin machinery is established by the blastocyst stage and that high levels of trypsin are associated with successful pregnancy. Treatment with LEFTY2 or combined treatment with LEFTY2 and trypsin blocked the increase of L-type Ca 2+ channel levels and activity. Treatment of endometrial cells with trypsin was followed by an increase of [Ca 2+ ]i, an effect that was significantly blunted by amiloride and LEFTY2. Further, the trypsin induced increase of [Ca 2+ ]i was significantly blunted by Ca 2+ channel inhibitor nifedipine. In the presence of nifedipine, LEFTY2 did not further modify trypsin induced increase of [Ca 2+ ]i. LEFTY2 significantly decreased levels of L-type Ca 2+ channel. Taken together, we demonstrate that high trypsin levels are associated with a positive pregnancy outcome and that infertility factor LEFTY2 down-regulates trypsin induced Ca 2+ increase due in part by interference with nifedipine sensitive Ca 2+ entry. These findings contribute further to our knowledge of unexplained infertility and failed IVF.